Skip navigation links
print | view as pdf | share

The Importance of Omega-3 Fatty Acids in the Attenuation of Immune-Mediated Diseases


The Importance of Omega-3 Fatty Acids in the Attenuation of Immune-Mediated Diseases

Hosted by: National Institute of Allergy and Infectious Diseases

Co-Sponsored by: Office of Dietary Supplements
&
National Center for Complementary and Alternative Medicine, NIH


September 18, 2000
Bethesda, MD

Agenda and Abstracts

8:30 Welcome and Opening Remarks
Patricia Kehn, Program Officer
Daniel Rotrosen, M.D., Director
Division of Allergy, Immunology and Transplantation, NIAID, NIH
8:40 Omega-3 Fatty Acids, Evolutionary Aspects and Metabolism
Artemis P. Simopoulos, M.D., Director
National Center for Genetics, Nutrition, and Health, Washington, DC
9:15 Omega-3 Lipids and Vitamin E Supplements on Immune Functions in Rheumatoid Arthritis Prone Mice
Jaya T. Venkatraman, Ph.D.
State University of New York at Buffalo, Buffalo, NY
9:50 Clinical Effects of Omega-3 Fatty Acid Dietary Supplementation in Patients with Rheumatoid Arthritis
Joel M. Kremer, M.D.
Albany Medical College, Albany, NY
10:30 BREAK
10:45 Dietary Omega-3 Polyunsaturated Fatty Acids Reduce Interleukin-12 and Interferon-gamma Production and Can Adversely Affect Host Infectious Disease Resistance
Kevin L. Fritsche, Ph.D.
University of Missouri, Columbia, MO
11:25 Development of a Safe and Effective Dietary Fatty Acid Supplement that Reduces Leukotriene Generation in Humans
Floyd H. Chilton III, Ph.D.
Wake Forest University School of Medicine and Pilot Therapeutics, Winston-Salem, NC
12:00 LUNCH BREAK
1:00 Developing a National Research Agenda for Complementary and Alternative Medicine
Stephen E. Straus, M.D., Director
National Center for Complementary and Alternative Medicine, NIH
1:15 Diet Modulation of Apoptosis
Robert S. Chapkin, Ph.D.
Texas A&M University, College Station, TX
1:50 Role of Omega-3 Fatty Acids and Calorie Restriction on Autoimmune Systemic Lupus Erythematosus
Gabriel J. Fernandes, Ph.D.
University of Texas Health Science Center at San Antonio, San Antonio, TX
2:25 Omega-3 Fatty Acids in the Treatment of Patients with IgA Nephropathy: The Rationale and the Studies
James V. Donadio, M.D.
Mayo Clinic and Foundation, Rochester, MN
3:00 Potential Mechanisms Whereby Fish Oil Protects Against Renal Disease
Joseph Grande, M.D., Ph.D.
Mayo Clinic and Foundation, Rochester, MN
3:20 Long Chain Unsaturated Fatty Acids and Reduction of Complications in Organ Transplantation
J. Wesley Alexander, M.D.
University of Cincinnati, Cincinnati, OH
4:00 Summary of Presentations
Gabriel Fernandes, Ph.D.
University of Texas
4:10 BREAK
4:25 Panel Discussion and Development of Research Agenda
Chaired by:
Gabriel Fernandes, Ph.D.

Participants:
Artemis P. Simopoulos, M.D.
Jaya T. Venkatraman, Ph.D.
Joel M. Kremer, M.D.
Kevin L. Fritsche, Ph.D.
Floyd H. Chilton III, Ph.D.
Robert S. Chapkin, Ph.D.
  James V. Donadio, M.D.
Joseph Grande, M.D., Ph.D.
J. Wesley Alexander, M.D.
Jill Norris, Ph.D.
Andrew Stoll, M.D.
5:30 ADJOURNMENT